All about Canadian investments. Learn the ins and outs and get the latest news.
Latest News
Erin Bury on quitting a stable job for a risky paycheque, investing in her 20s and more May 12th
Value and planning ahead are important for Erin Bury—as you will read in the interview below. It is what drives her as an entrepreneur (a former PR pro, she is the co-founder and chief executive officer of Willful, an online will platform making estate planning accessible to Canadians). Read on to.... More »
The best GIC rates in Canada for 2024 Nov 25th
GIC comparison tool
Find the best and most up-to-date GIC rates in Canada using the comparison tool below. Plus, use the filters to assess your estimated rate of return based on the size of your balance.
Why trust us
MoneySense is an award-winning magazine, helping Canadians navigat.... More »
Stock market news for Canadian investors: Cineplex, McDonald’s report earnings Feb 12th
Companies that reported earnings this week
Cineplex
McDonald’s
L.A. wildfires, U.S. tariff threats don’t have Cineplex execs worried
Source: Google
Cineplex (TSE: CGX)
Q4 earnings: $3.3 million or five cents per share, compared with a loss of $9.0 million or 14 cents pe.... More »
Oil prices rise above $100, North American stock market holds steady as U.S.-Iran tensions continue - CBC + MORE Apr 13th
Oil prices rise above $100, North American stock market holds steady as U.S.-Iran tensions continue CBCOil prices jump on US plans to blockade Iranian ports in Strait of Hormuz CNNPrice at the pump in Toronto could soon eclipse $2 a litre amid U.S threat to blockade Strait of H.... More »
Making sense of the markets this week: August 3 Aug 1st
Each week, Cut the Crap Investing founder Dale Roberts shares financial headlines and offers context for Canadian investors.
Gold outshines itself
Gold stole the headlines this week. That can happen when an infamous asset takes out its previous all-time highs.
Last Sunday, gold made another push a.... More »
Biotech stocks: are they worth a shot?
– moneysense.ca
There’s a hot new investment on the market that wouldn’t have been on many people’s radars only a few weeks ago: COVD-19 vaccine-makers. Since March 16, when quarantine began in earnest, Moderna, a Cambridge company that’s making a novel coronavirus vaccine, has climbed by 244%. Novavax, a Rockville, Maryland-based vaccine development company, has seen its shares skyrocket by 644% since mid-March. Shares of Vaxart, a little-known San Francisco-based company that’s developing an oral COVID-19 vaccine, have climbed by 736% since January. Those kinds of numbers would surely look good in any pandemic-hit portfolio right about now.
As exciting as the vaccine businesses may be, there is a better way to spend your money. Go to Vegas when the border reopens and put everything on black. While you might come back empty-handed, at least that loss comes with good food and a show.
You see, despite some huge gains over the last few weeks, and interest from investors big and small, betting on vaccines is no different than playing roulette…
As exciting as the vaccine businesses may be, there is a better way to spend your money. Go to Vegas when the border reopens and put everything on black. While you might come back empty-handed, at least that loss comes with good food and a show.
You see, despite some huge gains over the last few weeks, and interest from investors big and small, betting on vaccines is no different than playing roulette…
